Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 141.08M P/E - EPS this Y 38.60% Ern Qtrly Grth -
Income -23.7M Forward P/E -42.10 EPS next Y 48.80% 50D Avg Chg 20.00%
Sales 152.55M PEG - EPS past 5Y - 200D Avg Chg 82.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -23.00%
Recommedations 1.80 Quick Ratio 1.11 Shares Outstanding 39.09M 52W Low Chg 269.00%
Insider Own 19.81% ROA -21.52% Shares Float 30.96M Beta 1.43
Inst Own 30.81% ROE - Shares Shorted/Prior 2.33M/1.93M Price 4.21
Gross Margin 87.61% Profit Margin -13.50% Avg. Volume 358,162 Target Price 12.80
Oper. Margin -4.84% Earnings Date May 8 Volume 141,569 Change -5.39%
About LifeMD, Inc.

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

LifeMD, Inc. News
04/24/24 LifeMD to Report First Quarter 2024 Financial Results on May 8
04/23/24 LifeMD to Participate in Upcoming Investor and Industry Conferences During May
07:00 AM LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
03/25/24 LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03/13/24 LifeMD Full Year 2023 Earnings: Beats Expectations
03/11/24 LifeMD Reports Fourth Quarter 2023 Results
02/27/24 LifeMD Insiders Placed Bullish Bets Worth US$1.24m
08:00 AM LifeMD to Report Fourth Quarter 2023 Financial Results on March 11
02/15/24 LifeMD to Participate in Upcoming Investor Conferences and Webinar
01/31/24 LifeMD (NASDAQ:LFMD) shareholders have earned a 49% CAGR over the last five years
01/31/24 LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
01/22/24 Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
01/18/24 LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference
01/08/24 LifeMD Provides 2024 Financial Guidance
01/04/24 Why LifeMD's CEO isn't concerned about Eli Lilly's DTC site
01/04/24 LifeMD, Inc. (NASDAQ:LFMD) Shares Could Be 32% Above Their Intrinsic Value Estimate
12/13/23 LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
12/12/23 Is There Now An Opportunity In LifeMD, Inc. (NASDAQ:LFMD)?
12/07/23 LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium
12/05/23 Sidoti Events, LLC's Virtual December Small-Cap Conference
LFMD Chatroom

User Image Alex1965 Posted - 1 hour ago

$LFMD Could the run today be related ? Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. https://ir.medifastinc.com/2024-04-15-Medifast-to-Announce-Financial-Results-for-the-First-Quarter-Ended-March-31,-2024

User Image Steve1309 Posted - 1 hour ago

$LFMD weird day of trading. I predict Monday morning new partner news. These pharmaceuticals are having trouble operating direct distribution.... maybe LFMD negotiated being an outlet for a big pharmaceutical. Sweet dreams!

User Image Jasooon Posted - 2 hours ago

$LFMD ahhhh, I regret trimming! But still happy that I have good size position, I will be holding long term

User Image Steve1309 Posted - 2 hours ago

$LFMD maybe someone knows something... few cents away from 12 month high.

User Image Steve1309 Posted - 2 hours ago

$LFMD nobody selling and somebody nibbling at decent size chunks.

User Image Doozio Posted - 4 hours ago

$LFMD 1/4/24 Thursday 🐑 then 🧠⏰ is….

User Image Jasooon Posted - 5 hours ago

$LFMD, OK should I trim or nah? Tempted to take some profits...but it would be small trim as I would still hold a good-sized position and would hold core position long term.

User Image LoverGirl Posted - 23 hours ago

$HIMS $LFMD I finally bought a decent sized position in HIMS…expecting Q1 to be a blowout….will add more on further dips

User Image Alex1965 Posted - 1 day ago

$LFMD $HIMS U.S. GDP growth cools markedly in Q1, to its slowest pace in two years https://seekingalpha.com/news/4094072-us-gross-domestic-product-growth-cools-markedly-in-q1

User Image FringDook Posted - 1 day ago

$LFMD this one seems to be holding up in todays down market

User Image Alex1965 Posted - 1 day ago

$LFMD $HIMS Novo Nordisk comes under Senate probe over pricing for weight loss drugs https://seekingalpha.com/news/4093539-novo-nordisk-senate-probe-wegovy-pricing?hasComeFromMpArticle=false

User Image Alex1965 Posted - 1 day ago

$LFMD $HIMS 3.6M Medicare patients could qualify for Wegovy coverage: report https://seekingalpha.com/news/4093197-36m-medicare-patients-could-qualify-for-wegovy-coverage-report?mailingid=35142693&messageid=2900&serial=35142693.1700&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=35142693.1700

User Image Jasooon Posted - 1 day ago

$TALK $LFMD $HIMS, Optum exiting virtual care business. Gives you appreciation on running a high growing telehealth business, which is hard.

User Image Alex1965 Posted - 1 day ago

$LFMD UnitedHealth to wind down Optum telehealth business https://seekingalpha.com/news/4093400-unitedhealth-wind-down-optum-telehealth-business

User Image Alex1965 Posted - 1 day ago

$LFMD My investing thesis of LifeMD

User Image Itsallaponzischeme Posted - 2 days ago

$LFMD honestly could this get up to the triple digits soon? It’s only 39 million shares outstanding. And it’s such a solid company teledoc went to 200 plus in 2021. Do you all think that it’s highly likely to do so?

User Image futurerobo34 Posted - 2 days ago

$LFMD @Jasooon there are some cognitively impaired morons on the Dario board. These jokers think a 30 cent gain after dropping from $15 dollars over a 2 year span is a win 🙄. LFMD and Talk have made my “loss” in Dario bearable.

User Image Figisbest Posted - 2 days ago

@Smac57 @rolypoly101 I think it’s good. This is how “the game” is played. BTIG has done a lot of work on this name. They probably “know” (perhaps without really knowing but lots of hinting) that management is going to have a good quarter and the trajectory is positive. Come out with a $14 price target ahead of earnings. Magically $LFMD has a good Q, stock rallies to meet the price target and the numbers justify BTIG coming out with a new, and higher, price target of $18 or maybe even $20. Which if the numbers (fundamentals) continue to improve, the same game takes place going into the next quarter where the stock hits the new $18 or $20 price target. Then numbers come out and a new higher target ensues. Or I hope this is what happens!

User Image Steve1309 Posted - 2 days ago

$LFMD $LFMDP earlier than usual?

User Image Stock_Titan Posted - 2 days ago

$LFMD $LFMDP LifeMD to Report First Quarter 2024 Financial Results on May 8 https://www.stocktitan.net/news/LFMD/life-md-to-report-first-quarter-2024-financial-results-on-may-wrkqoez40yqz.html

User Image StarLord13 Posted - 3 days ago

$TDOC Jeezus! I remember $LFMD was 1.75 when $TDOC was 80 dollars a share. $LFMD about to surpass $TDOC now. What happened? 😱

User Image BuyNowUnlimited Posted - 3 days ago

$HIMS $LFMD almost back to all time high 😭😭

User Image Smac57 Posted - 3 days ago

$LFMD Well if this is the reason for the price movement, I hope they come out tomorrow and retract it, saying they made a mistake, and it should be $18.

User Image Steve1309 Posted - 3 days ago

$LFMD yeah yeah... just hold this time

User Image dick_dasterdly Posted - 3 days ago

$LFMD Don't know what happened.. don't care. Ladies and gentlemen the seat belt light is on. Strap in !

User Image Ma2B Posted - 3 days ago

$LFMD I guess "they" gave up on holding this one back any longer

User Image Telfo22 Posted - 3 days ago

$LFMD are you not entertained????

User Image rolypoly101 Posted - 3 days ago

$LFMD BTIG raises PT to $14 https://www.benzinga.com/quote/LFMD/analyst-ratings

User Image FringDook Posted - 3 days ago

$LFMD this board has become quiet

User Image Alex1965 Posted - 3 days ago

$LFMD May will be a busy month. A total of 8 events LifeMD to Participate in Upcoming Investor and Industry Conferences During May NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. today announced that management will be participating in the following investor and industry conferences during the month of May: BTIG Obesity Health Forum, May 8, 2024. Management will participate in a virtual panel titled Obesity Management with Coaching, Eating, and Lifestyle Management moderated by equity research analyst David Larsen. Citizens JMP Securities Life Sciences Conference, May 13-14, 2024 at the New York Hilton Midtown. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors. Obesity+Health Conference hosted by Digital Health New York, May 14, 2024 at NYU Langone Health. LifeMD’s Chief Medical Officer Dr. Anthony Puopolo will speak about optimal obesity care on a panel with other thought leaders.

Analyst Ratings
BTIG Buy Apr 23, 24
BTIG Buy Mar 15, 24
Craig-Hallum Buy Mar 12, 24
B. Riley Securities Buy Mar 12, 24
Cantor Fitzgerald Overweight Mar 12, 24
HC Wainwright & Co. Buy Mar 12, 24
HC Wainwright & Co. Buy Jan 11, 24
Cantor Fitzgerald Overweight Dec 14, 23
Craig-Hallum Buy Nov 30, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Jindal Piyush Director Director Nov 06 Option 2.52 37,500 94,500 337,500 11/08/23
Velge Bertrand Director Director Jun 07 Buy 2.41 73,965 178,256 213,465 09/01/23
Velge Bertrand Director Director Nov 02 Buy 3.76 132,072 496,591 349,482 08/31/23
Alvarez Nicholas P Chief Acquisition Of.. Chief Acquisition Officer Jun 14 Buy 2.92 10,712 31,279 180,000 06/15/23
Yecies Eric Harold General Counsel & CC.. General Counsel & CCO Jun 13 Buy 2.6 11,500 29,900 62,500 06/14/23
Velge Bertrand Director Director Jun 05 Buy 2.17 139,500 302,715 139,500 06/07/23
Galluppi Stefan Chief Innovation Off.. Chief Innovation Officer May 23 Buy 2.17 4,608 9,999 12,449 05/31/23
Schreiber Justin CEO CEO May 22 Buy 2.11 50,000 105,500 2,844,620 05/24/23
DiTrolio Joseph Director Director Mar 10 Buy 3.28 2,000 6,560 24,500 03/11/22
Benathen Marc David Chief Financial Offi.. Chief Financial Officer Aug 18 Buy 7.29 3,067 22,358 19,723 08/18/21